Suzhou, China

Zhiwei Pan

This inventor holds 1 USPTO granted patent. Top assignees: Shanghai Junshi Biosciences Inc., Suzhou Junmeng Biosciences Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhiwei Pan. Retrieved from https://idiyas.com/inventor/zhiwei-pan-ne52grm1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhiwei Pan: Innovator in Antibody Development

Introduction

Zhiwei Pan is a notable inventor based in Suzhou, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work has implications for therapeutic applications, showcasing the potential of innovative solutions in medicine.

Latest Patents

Zhiwei Pan holds a patent titled "Anti-CTLA-4 Antibody and Use Thereof." This patent represents a critical advancement in the understanding and treatment of various diseases, particularly in the realm of immunotherapy.

Career Highlights

Throughout his career, Zhiwei Pan has worked with prominent companies in the biotechnology sector. He has been associated with Shanghai Junshi Biosciences Inc. and Suzhou Junmeng Biosciences Co., Ltd. His experience in these organizations has allowed him to contribute to groundbreaking research and development efforts.

Collaborations

Zhiwei Pan has collaborated with esteemed colleagues, including Jian Yao and Jing Zhang. These partnerships have fostered a collaborative environment that enhances innovation and drives progress in their respective fields.

Conclusion

Zhiwei Pan's contributions to antibody development and his innovative spirit exemplify the impact of dedicated inventors in the biotechnology industry. His work continues to inspire advancements that may lead to significant improvements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…